Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine.

MLA

Zhao, Yongqiang, et al. “Cross-Protection against Homo and Heterologous Influenza Viruses via Intranasal Administration of an HA Chimeric Multiepitope Nanoparticle Vaccine.” Journal of Nanobiotechnology, vol. 23, no. 1, Feb. 2025, p. 77. EBSCOhost, https://doi.org/10.1186/s12951-025-03122-6.

APA

Zhao, Y., Liu, J., Peng, C., Guo, S., Wang, B., Chen, L., Wang, Y., Tang, H., Liu, L., Pan, Q., Li, S., Wang, J., Yang, D., & Du, E. (2025). Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine. Journal of Nanobiotechnology, 23(1), 77. https://doi.org/10.1186/s12951-025-03122-6

Chicago

Zhao, Yongqiang, Jia Liu, Chun Peng, Shuangshuang Guo, Bo Wang, Longping Chen, Yating Wang, et al. 2025. “Cross-Protection against Homo and Heterologous Influenza Viruses via Intranasal Administration of an HA Chimeric Multiepitope Nanoparticle Vaccine.” Journal of Nanobiotechnology 23 (1): 77. doi:10.1186/s12951-025-03122-6.